AUG 05, 2019 3:14 PM PDT

Is Mankai Duckweed the Next Superfood?

WRITTEN BY: Tiffany Dazet

Acai, kale, and quinoa are just a few foods that have been labeled as “superfoods” in recent years. Superfoods are those which contain healthy compounds such as antioxidants, fiber, or fatty acids. They’re alleged to boost health and vitality in numerous ways including regulating cholesterol and blood pressure and preventing cancer. The term “superfood” is not scientifically regulated, and it is commonly used to establish health trends and marketing verbiage. 

However, scientists do study certain “superfoods” to discover their biomedical advantages. Additionally, as food resources are challenged by population growth and climate change, discovering new sources of healthy foods is of vital concern. Mankai duckweed is one such superfood that is being studied for its health benefits, as well as its potential to become a more widely used protein source. 

What is duckweed? According to the USDA and U.S. Forest Services, duckweeds are the smallest flowering plants currently in existence and are found in freshwater aquatic habitats such as ponds and lakes. Most duckweeds are a single, flat oval leaf with a maximum size of 0.25 inch. The grow so quickly they can be considered a nuisance by humans, but they’re also an important food source for waterfowl and fishes. Duckweeds are also sometimes called “water lentils” when used in human foods or dietary supplements.

Mankai duckweed—Wolffia globosa—is a high-protein type of this aquatic plant, containing 45% protein. Previous studies have demonstrated Mankai duckweed’s viability as a healthy protein source as well as a unique source of B12. A study from earlier this year showed that incorporating Mankai into a Mediterranean diet can result in healthy iron and folic acid levels (without red meat). Most recently, a team of researchers from Ben-Gurion University of the Negev (BGU) discovered Mankai duckweed’s ability to provide glycemic control after carbohydrate consumption. The results of the study were published in the American Diabetes Association’s Diabetes Care journal last month.

To assess Mankai duckweed’s impact on glucose levels, study participants were given a green shake containing Mankai duckweed or a yogurt shake equivalent. They monitored the participants’ glucose dynamics for two weeks. The results of the study showed that the participants who drank the duckweed shake had lower glucose peak levels, morning fasting glucose levels, later peak time, and faster glucose evacuation. Participants also reported feeling fuller. These results further bolster duckweeds’ status as an emerging superfood and protein replacement.

Sources: US Forestry Service, Science Daily, Diabetes Care
 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
AUG 27, 2021
Cell & Molecular Biology
Common Pesticide May Lead to Weight Gain
AUG 27, 2021
Common Pesticide May Lead to Weight Gain
Globally, obesity rates have been rising for years. Research has indicated that a western diet that's high in fat, sugar ...
AUG 28, 2021
Neuroscience
Postponing Retirement May Protect Cognitive Function
AUG 28, 2021
Postponing Retirement May Protect Cognitive Function
Retiring at a later age may protect against cognitive decline. The corresponding study was published in SSM- Popula ...
SEP 08, 2021
Health & Medicine
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
SEP 08, 2021
Gene Linked to Endometriosis Could Lead to Non-Hormonal Treatment Options
Researchers from the University of Oxford found an association between neuropeptide S receptor 1 (NPSR1) gene variants a ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
SEP 14, 2021
Health & Medicine
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
SEP 14, 2021
The Magnitude of Cardiovascular Disease- New Insights and Ways Forward
Among healthcare professionals, it is common knowledge that cardiovascular disease is the leading cause of death in the ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...